Icon

KIMYRSA (nda214155)- (EQ 1.2GM BASE/VIAL)

ORITAVANCIN DIPHOSPHATE MELINTA THERAP
EQ 1.2GM BASE/VIAL
No No
2035-Jul-16 2019-Aug-06
None 2024-Mar-12
2024-Aug-06 No
KIMYRSA is a lipoglycopeptide antibacterial drug indicated for the treatment of adult patients with acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 1.2GM BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.